ANZILOTTI, Serenella
 Distribuzione geografica
Continente #
NA - Nord America 625
EU - Europa 146
AS - Asia 33
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 821
Nazione #
US - Stati Uniti d'America 600
UA - Ucraina 34
IT - Italia 29
CA - Canada 25
DE - Germania 25
SE - Svezia 23
CN - Cina 21
CI - Costa d'Avorio 15
FI - Finlandia 14
BE - Belgio 8
FR - Francia 7
TR - Turchia 7
IN - India 4
GB - Regno Unito 2
NL - Olanda 2
NO - Norvegia 2
CO - Colombia 1
EU - Europa 1
IR - Iran 1
Totale 821
Città #
Chandler 225
Princeton 30
Jacksonville 25
Boydton 23
Toronto 21
Abidjan 15
Helsinki 14
Ogden 14
Ann Arbor 10
Formia 10
Boardman 9
Brussels 8
Istanbul 7
Nanjing 7
Wilmington 6
Brooklyn 5
Seattle 5
Andover 4
Ashburn 4
Pune 4
Shenyang 4
Caserta 3
Houston 3
Nanchang 3
Pontecagnano 3
Strasbourg 3
Borås 2
Dearborn 2
Edinburgh 2
Gunzenhausen 2
Meppel 2
Montreal 2
Oslo 2
Rome 2
San Mateo 2
Tianjin 2
West Jordan 2
Ardabil 1
Benevento 1
Buffalo 1
Canosa Di Puglia 1
Castel Campagnano 1
Chicago 1
Florence 1
Frankfurt am Main 1
Hangzhou 1
Hebei 1
Las Vegas 1
Medellín 1
Monmouth Junction 1
Mykolayiv 1
Naples 1
Napoli 1
Ningbo 1
Norwalk 1
Ottawa 1
Portland 1
Santa Maria Capua Vetere 1
Taizhou 1
Varese 1
Zhengzhou 1
Totale 511
Nome #
Pharmacological Characterization of the Newly Synthesized 5-Amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide Hydrochloride (BED) as a Potent NCX3 Inhibitor That Worsens Anoxic Injury in Cortical Neurons, Organotypic Hippocampal Cultures, and Ischemic Brain 64
MC1568 inhibits thimerosal-induced apoptotic ell death by preventing HDAC4 up-regulation in neuronal cells and in rat prefrontal cortex 56
Methylmercury upregulates RE-1 silencing transcription factor (REST) in SH-SY5Y cells and mouse cerebellum. 53
Resveratrol via sirtuin-1 downregulates RE1-silencing transcription factor (REST) expression preventing PCB-95-induced neuronal cell death. 51
Ionic homeostasis maintenance in ALS: Focus on new therapeutic targets 44
Prolonged NCX activation prevents SOD1 accumulation, reduces neuroinflammation, ameliorates motor behavior and prolongs survival in a ALS mouse model 34
Changes in the expression of extracellular regulated kinase (ERK 1/2) in the R6/2 mouse model of Huntington's disease after phosphodiesterase IV inhibition 29
HDAC4 and HDAC5 form a complex with DREAM that epigenetically down-regulates NCX3 gene and its pharmacological inhibition reduces neuronal stroke damage 28
Models and methods for conditioning the ischemic brain 26
Neuroprotective Effect of VEGF-Mimetic Peptide QK in Experimental Brain Ischemia Induced in Rat by Middle Cerebral Artery Occlusion 25
Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease 25
GATA3 (GATA-Binding Protein 3)/KMT2A (Lysine-Methyltransferase-2A) Complex by Increasing H3K4-3me (Trimethylated Lysine-4 of Histone-3) Upregulates NCX3 (Na+-Ca2+Exchanger 3) Transcription and Contributes to Ischemic Preconditioning Neuroprotection 25
Acute and long-term NCX activation reduces brain injury and restores behavioral functions in mice subjected to neonatal brain ischemia 24
Immunohistochemical localization of receptor for advanced glycation end (RAGE) products in the R6/2 mouse model of Huntington's disease 24
In vivo imaging of CNS microglial activation/macrophage infiltration with combined [18F]DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis 24
Anti-miR-223-5p Ameliorates Ischemic Damage and Improves Neurological Function by Preventing NCKX2 Downregulation after Ischemia in Rats 23
Sumoylation of LYS590 of NCX3 f-Loop by SUMO1 Participates in Brain Neuroprotection Induced by Ischemic Preconditioning 22
Genetic Up-Regulation or Pharmacological Activation of the Na+/Ca2+ Exchanger 1 (NCX1) Enhances Hippocampal-Dependent Contextual and Spatial Learning and Memory 22
Preconditioning, induced by sub-toxic dose of the neurotoxin L-BMAA, delays ALS progression in mice and prevents Na+/Ca2+ exchanger 3 downregulation 21
Genetic ablation of homeodomain-interacting protein kinase 2 selectively induces apoptosis of cerebellar Purkinje cells during adulthood and generates an ataxic-like phenotype 21
Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease 20
Does Na⁺/Ca²⁺ exchanger, NCX, represent a new druggable target in stroke intervention? 20
miR-206 Reduces the Severity of Motor Neuron Degeneration in the Facial Nuclei of the Brainstem in a Mouse Model of SMA 19
Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with (18)F-DPA-714 and micro-PET/CT 19
Ischemic tolerance modulates TRAIL expression and its receptors and generates a neuroprotected phenotype 19
Sodium/calcium exchanger as main effector of endogenous neuroprotection elicited by ischemic tolerance 18
Ionic homeostasis in brain conditioning 16
Sumoylation of sodium/calcium exchanger in brain ischemia and ischemic preconditioning 16
Remote postconditioning ameliorates stroke damage by preventing let-7a and miR-143 up-regulation 12
Chronic exposure to l-BMAA cyanotoxin induces cytoplasmic TDP-43 accumulation and glial activation, reproducing an amyotrophic lateral sclerosis-like phenotype in mice 11
Triticum vulgare extract exerts an anti-inflammatory action in two in vitro models of inflammation in microglial cells 9
Preconditioning in hypoxic-ischemic neonate mice triggers Na+-Ca2+ exchanger-dependent neurogenesis 5
Stroke Causes DNA Methylation at Ncx1 Heart Promoter in the Brain Via DNMT1/MeCP2/REST Epigenetic Complex 5
Stroke by inducing HDAC9-dependent deacetylation of HIF-1 and Sp1, promotes TfR1 transcription and GPX4 reduction, thus determining ferroptotic neuronal death 4
miR135a administration ameliorates brain ischemic damage by preventing TRPM7 activation during brain ischemia 3
Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIB 2
Anti-miRNA103/107 encapsulated in transferrin-conjugated lipid nanoparticles crosses blood-brain barrier and reduces brain ischemic damage 2
Totale 841
Categoria #
all - tutte 6.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.082


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201913 0 0 0 0 0 0 0 0 0 2 2 9
2019/202044 13 0 1 5 2 6 2 7 0 6 0 2
2020/202164 5 5 3 4 3 14 1 5 8 8 7 1
2021/202268 5 2 15 3 0 0 1 4 2 1 1 34
2022/2023496 71 20 5 75 24 96 0 58 106 14 26 1
2023/2024149 13 32 40 3 5 2 5 8 36 5 0 0
Totale 841